Chondroma natural history

Jump to navigation Jump to search

Chondroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Cause

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Chondroma from other Diseases

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Chondroma natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chondroma natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chondroma natural history

CDC on Chondroma natural history

Chondroma natural history in the news

Blogs on Chondroma natural history

Directions to Hospitals Treating Chondroma

Risk calculators and risk factors for Chondroma natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2], Soujanya Thummathati, MBBS [3]

Overview

Chondroma is usually diagnosed incidentally. Common complications of chondroma include malignant transformation into a low grade growth disturbance, pathologic fracture, especially in short tubular bones and recurrence. Benign chondromas have a good prognosis with appropriate treatment.

Natural History

  • Chondroma is usually diagnosed incidentally.[1]
  • Chondroma grows slowly, with a mean time of 41 months between initial diagnosis and change in lesion.

Complications

Prognosis

References

  1. Deckers C, Schreuder BH, Hannink G, de Rooy JW, van der Geest IC (December 2016). "Radiologic follow-up of untreated enchondroma and atypical cartilaginous tumors in the long bones". J Surg Oncol. 114 (8): 987–991. doi:10.1002/jso.24465. PMID 27696436.
  2. Palaoglu S, Akkas O, Sav A (1988). "Chondroma of the cervical spine". Clin Neurol Neurosurg. 90 (3): 253–5. PMID 3197353.
  3. Müller PE, Dürr HR, Nerlich A, Pellengahr C, Maier M, Jansson V (June 2004). "Malignant transformation of a benign enchondroma of the hand to secondary chondrosarcoma with isolated pulmonary metastasis". Acta Chir. Belg. 104 (3): 341–4. PMID 15285552.
  4. Martin JA, Forest E, Block JA, Klingelhutz AJ, Whited B, Gitelis S, Wilkey A, Buckwalter JA (September 2002). "Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation". Cell Growth Differ. 13 (9): 397–407. PMID 12354749.
  5. Choi E, Wert M, Guerrieri C, Tucci J (November 2010). "A pathologic fracture of an intracortical chondroma masking as an osteoid osteoma". Orthopedics. 33 (11): 845. doi:10.3928/01477447-20100924-24. PMID 21053879.
  6. Freilich H (June 1991). "Breast cancer screening". Med. J. Aust. 154 (11): 781–2. PMID 1888368.
  7. Rozeman LB, Hogendoorn PC, Bovée JV (September 2002). "Diagnosis and prognosis of chondrosarcoma of bone". Expert Rev. Mol. Diagn. 2 (5): 461–72. doi:10.1586/14737159.2.5.461. PMID 12271817.


Template:WikiDoc Sources